METHYLPREDNISOLONE for Dermatitis: Side Effects & Safety Data
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
There are 18 adverse event reports in the FDA FAERS database where METHYLPREDNISOLONE was used for Dermatitis.
Most Reported Side Effects for METHYLPREDNISOLONE
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Off label use | 10,364 | 16.2% | 2,842 | 4,839 |
| Drug ineffective | 9,959 | 15.6% | 2,776 | 4,831 |
| Product use in unapproved indication | 4,115 | 6.4% | 1,482 | 1,619 |
| Condition aggravated | 3,784 | 5.9% | 1,548 | 2,136 |
| Headache | 3,419 | 5.4% | 1,128 | 1,653 |
| Fatigue | 3,250 | 5.1% | 1,192 | 1,622 |
| Pyrexia | 3,226 | 5.1% | 998 | 2,014 |
| Pain | 3,165 | 5.0% | 1,348 | 1,532 |
| Nausea | 3,105 | 4.9% | 989 | 1,793 |
| Pneumonia | 3,006 | 4.7% | 1,598 | 1,933 |
| Rash | 3,005 | 4.7% | 1,367 | 1,511 |
| Hypertension | 2,801 | 4.4% | 1,372 | 1,378 |
| Diarrhoea | 2,684 | 4.2% | 1,199 | 1,648 |
| Dyspnoea | 2,592 | 4.1% | 942 | 1,568 |
| Rheumatoid arthritis | 2,381 | 3.7% | 1,301 | 1,227 |
Other Indications for METHYLPREDNISOLONE
Product used for unknown indication (9,568)
Immunosuppressant drug therapy (5,162)
Premedication (2,339)
Immunosuppression (2,041)
Covid-19 (1,633)
Rheumatoid arthritis (1,298)
Prophylaxis against transplant rejection (1,274)
Systemic lupus erythematosus (1,135)
Renal transplant (1,090)
Acute lymphocytic leukaemia (1,022)
Other Drugs Used for Dermatitis
DUPILUMAB (9,959)
CRISABOROLE (407)
APREMILAST (122)
TRALOKINUMAB-LDRM (90)
KETOCONAZOLE (66)
CYCLOSPORINE (62)
DOXYCYCLINE (57)
PIMECROLIMUS (55)
CLOBETASOL (50)
RUXOLITINIB (50)